Search - tctmd.com

Displaying 541 - 560 of 659

Sort: Relevancy | Date

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Industry News

China Interventional Cardiovascular Device Industry Report, 2014-2017

May 27, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

Presentation CADECI 2015

The future of Drug-Eluting Stent

Presenter: Renu Virmani

February 18, 2015

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Salynn Boyles

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Salynn Boyles

November 02, 2014

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

L.A. McKeown

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

News Daily News

Los SLF Parecen Seguros y Efectivos para PCI en IVS

Salynn Boyles

October 24, 2014

News Daily News

DES Appear Safe and Effective in SVG PCI

Salynn Boyles

October 24, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Drug Eluting Stents Versus Coronary Artery Bypass Graft surgery for Isolated Proximal Left Anterior Descending Artery Stenosis: A Meta-analysis

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Presenter: Jacek Bil

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

Presentation TCT 2014

Do Drug-Eluting Balloons Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Kenneth Chin

September 15, 2014

Advertisement

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

China Interventional Cardiovascular Device Industry Report, 2014-2017

Evolving DES Technology May Benefit Diabetic Patients

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

The future of Drug-Eluting Stent

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Los SLF Parecen Seguros y Efectivos para PCI en IVS

DES Appear Safe and Effective in SVG PCI

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Drug Eluting Stents Versus Coronary Artery Bypass Graft surgery for Isolated Proximal Left Anterior Descending Artery Stenosis: A Meta-analysis

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Do Drug-Eluting Balloons Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content